Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-122087
Filing Date
2025-05-19
Accepted
2025-05-19 06:50:17
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d830217d424b5.htm 424B5 1106293
2 GRAPHIC g830217g04r34.jpg GRAPHIC 166070
3 GRAPHIC g830217g10j07.jpg GRAPHIC 62245
4 GRAPHIC g830217g41p95.jpg GRAPHIC 61615
5 GRAPHIC g830217g84p82.jpg GRAPHIC 21057
  Complete submission text file 0001193125-25-122087.txt   1537942
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284770 | Film No.: 25961458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PIET HEINKADE 107 AMSTERDAM P7 1019 GM
Business Address PIET HEINKADE 107 AMSTERDAM P7 1019 GM 31(0) 20-2193000
Teva Pharmaceutical Finance Netherlands II B.V. (Filer) CIK: 0001628587 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284770-03 | Film No.: 25961461

Mailing Address PIET HEINKADE 107 AMSTERDAM P7 1019 GM
Business Address PIET HEINKADE 107 AMSTERDAM P7 1019 GM 31 (0)20-2193000
Teva Pharmaceutical Finance Netherlands IV B.V. (Filer) CIK: 0001679174 (see all company filings)

EIN.: 000000000
Type: 424B5 | Act: 33 | File No.: 333-284770-01 | Film No.: 25961460

Mailing Address PIET HEINKADE 107 AMSTERDAM P7 1019 GM
Business Address PIET HEINKADE 107 AMSTERDAM P7 1019 GM 31 (0)20-2193000
Teva Pharmaceutical Finance Netherlands III B.V. (Filer) CIK: 0001679183 (see all company filings)

EIN.: 000000000
Type: 424B5 | Act: 33 | File No.: 333-284770-02 | Film No.: 25961459